Filing Details
- Accession Number:
- 0001593968-22-000168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-06 14:45:20
- Reporting Period:
- 2022-01-04
- Accepted Time:
- 2022-01-06 14:45:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1673772 | Rapt Therapeutics Inc. | RAPT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1400901 | William Ho | C/O Rapt Therapeutics, Inc., 561 Eccles Avenue South San Francisco CA 94080 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-04 | 1,737 | $6.18 | 58,843 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-01-04 | 1,736 | $6.30 | 60,579 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-01-04 | 2,305 | $12.00 | 62,884 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-05 | 2,000 | $40.00 | 60,884 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2022-01-04 | 1,737 | $0.00 | 1,737 | $6.18 |
| Common Stock | Option (right to buy) | Disposition | 2022-01-04 | 1,736 | $0.00 | 1,736 | $6.30 |
| Common Stock | Option (right to buy) | Disposition | 2022-01-04 | 2,305 | $0.00 | 2,305 | $12.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-03-27 | No | 4 | M | Direct | |
| 4,167 | 2029-03-27 | No | 4 | M | Direct | |
| 10,122 | 2029-10-29 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
Billionaire Hedge Funds
